Genmab Market Cap

Genmab has a market cap or net worth of $13.21 billion as of July 15, 2025. Its market cap has decreased by -19.04% in one year.

Market Cap

13.21B

Enterprise Value

9.88B

Revenue

3.23B

Ranking

n/a

PE Ratio

11.59

Stock Price

$214.95

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 415.12M to 13.21B, an increase of 3,082.83%. That is a compound annual growth rate of 15.00%.

Market Cap History

Date	Market Cap	% Change
Jul 14, 2025	13.21B	0.14%
Dec 30, 2024	13.19B	-36.79%
Dec 29, 2023	20.88B	-24.42%
Dec 30, 2022	27.62B	5.40%
Dec 30, 2021	26.20B	-1.50%
Dec 30, 2020	26.60B	83.75%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Veradigm	857.64M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	553.58M
Glass House Brands	545.56M
CytoDyn	394.14M
American Oncology Network	343.79M

Market Cap Rankings